Literature DB >> 23902595

Phlebosclerotic colitis that was difficult to distinguish from collagenous colitis.

Hideaki Hozumi1, Ryota Hokari, Motonori Shimizu, Koji Maruta, Kazuyuki Narimatsu, Hirokazu Sato, Shingo Sato, Toshihide Ueda, Masaaki Higashiyama, Chikako Watanabe, Shunsuke Komoto, Kengo Tomita, Atsushi Kawaguchi, Shigeaki Nagao, Soichiro Miura.   

Abstract

Phlebosclerotic colitis is a rare and recently known disease entity and its etiology is still to be elucidated. Some phlebosclerotic colitis cases are difficult to distinguish from collagenous colitis because of the similarity of pathological findings. In all Japanese case reports of phlebosclerotic colitis in which an association with the use of Chinese herbal medicine is suspected, sansisi (gardenia fruit) was included, suggesting pathogenesis of this disease. We report a case of phlebosclerotic colitis that wasdifficult to be distinguished from collagenous colitis, and an association with the use of Chinese herbal medicine was suspected as the cause of the disease.
© 2013 The Authors. Digestive Endoscopy © 2013 Japan Gastroenterological Endoscopy Society.

Entities:  

Keywords:  Chinese herbal medicine; collagenous colitis; gardenia fruit; idiopathic mesenteric phlebosclerosis; phlebosclerotic colitis

Mesh:

Substances:

Year:  2013        PMID: 23902595     DOI: 10.1111/den.12151

Source DB:  PubMed          Journal:  Dig Endosc        ISSN: 0915-5635            Impact factor:   7.559


  4 in total

Review 1.  Idiopathic mesenteric phlebosclerosis associated with long-term use of medical liquor: two case reports and literature review.

Authors:  Fang Guo; Yu-Fen Zhou; Fan Zhang; Fei Yuan; Yao-Zong Yuan; Wei-Yan Yao
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

2.  Phlebosclerotic Colitis in a Healthy Young Woman.

Authors:  Jung Kyu Park; Young Ho Sung; Sun Young Cho; Chang Yul Oh; So Hyun An
Journal:  Clin Endosc       Date:  2015-09-30

3.  Total dosage of gardenia fruit used by patients with mesenteric phlebosclerosis.

Authors:  Yutaka Nagata; Tetsuo Watanabe; Kazuhiko Nagasaka; Masaaki Yamada; Masafumi Murai; Sunao Takeuchi; Mai Murase; Toshinori Yazaki; Takayuki Murase; Kenichi Komatsu; Machiko Kaizuka; Mika Sano; Koji Asano; Chikao Ando; Norihide Taniuchi
Journal:  BMC Complement Altern Med       Date:  2016-07-11       Impact factor: 3.659

4.  Phlebosclerotic colitis: Our clinical experience of 25 patients in China.

Authors:  Wenguo Chen; Huatuo Zhu; Hongtan Chen; Guodong Shan; Guoqiang Xu; Lihua Chen; Fei Dong
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.